Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1989 1
1990 1
1996 1
1997 2
1998 2
1999 1
2000 5
2001 4
2002 6
2003 2
2004 3
2005 6
2006 6
2008 1
2009 6
2010 4
2011 4
2012 6
2013 5
2014 1
2015 3
2016 8
2017 6
2018 8
2019 8
2020 12
2021 8
2022 9
2023 9
2024 7
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.
Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions.
Gerosa R, De Sanctis R, Jacobs F, Benvenuti C, Gaudio M, Saltalamacchia G, Torrisi R, Masci G, Miggiano C, Agustoni F, Pedrazzoli P, Santoro A, Zambelli A. Gerosa R, et al. Among authors: masci g. Crit Rev Oncol Hematol. 2024 Apr;196:104324. doi: 10.1016/j.critrevonc.2024.104324. Epub 2024 Mar 8. Crit Rev Oncol Hematol. 2024. PMID: 38462150 Free article. Review.
Imaging of Peritoneal Surface Malignancies.
Caruso D, Sammartino P, Polici M, Masci G, Biacchi D, Zerunian M, Scuto D, Gallotti MG, Iafrate F, Laghi A. Caruso D, et al. Among authors: masci g. J Surg Oncol. 2024 Nov;130(6):1203-1212. doi: 10.1002/jso.27979. Epub 2024 Nov 7. J Surg Oncol. 2024. PMID: 39508563 Free PMC article. Review.
Aromatase inhibitors in premenopause: Great expectations fulfilled?
Torrisi R, Rota S, Losurdo A, Zuradelli M, Masci G, Santoro A. Torrisi R, et al. Among authors: masci g. Crit Rev Oncol Hematol. 2016 Nov;107:82-89. doi: 10.1016/j.critrevonc.2016.08.009. Epub 2016 Aug 28. Crit Rev Oncol Hematol. 2016. PMID: 27823654 Review.
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial.
Stefanini G, Carlo-Stella C, Cannata F, Chiarito M, Figliozzi S, Novelli L, Lisi C, Bombace S, Catapano F, Indolfi E, Panico C, Corrado F, Masci G, Mazza R, Ricci F, Monti L, Ferrante G, Reimers B, Santoro A, Francone M, da Costa BR, Jüni P, Condorelli G. Stefanini G, et al. Among authors: masci g. Cardiovasc Res. 2025 Apr 22;121(2):227-229. doi: 10.1093/cvr/cvae266. Cardiovasc Res. 2025. PMID: 39842858 Free PMC article. No abstract available.
The stiff elbow: Current concepts.
Masci G, Cazzato G, Milano G, Ciolli G, Malerba G, Perisano C, Greco T, Osvaldo P, Maccauro G, Liuzza F. Masci G, et al. Orthop Rev (Pavia). 2020 Jun 25;12(Suppl 1):8661. doi: 10.4081/or.2020.8661. eCollection 2020 Jun 29. Orthop Rev (Pavia). 2020. PMID: 32913596 Free PMC article.
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer.
Saltalamacchia G, Torrisi R, De Sanctis R, Masci G, Miggiano C, Gaudio M, Benvenuti C, Jacobs F, Gerosa R, Santoro A, Zambelli A. Saltalamacchia G, et al. Among authors: masci g. Biomedicines. 2024 Feb 23;12(3):500. doi: 10.3390/biomedicines12030500. Biomedicines. 2024. PMID: 38540113 Free PMC article. Review.
Activated factor XI-antithrombin and thrombin-antithrombin complexes in the prediction of venous thromboembolism and mortality in patients with non-small-cell lung cancer.
Gomez-Rosas P, Nagy M, Spronk HMH, Russo L, Gamba S, Tartari CJ, Bolognini S, Ticozzi C, Schieppati F, Sarmiento R, De Braud F, Masci G, Tondini C, Petrelli F, Giuliani F, D'Alessio A, Santoro A, Gasparini G, Labianca R, Cate HT, Falanga A, Marchetti M; HYPERCAN Investigators. Gomez-Rosas P, et al. Among authors: masci g. J Thromb Haemost. 2025 Jun;23(6):1908-1919. doi: 10.1016/j.jtha.2025.02.029. Epub 2025 Mar 6. J Thromb Haemost. 2025. PMID: 40056983
146 results